Developing a standardized approach to cancer medication-related infusion reaction prevention and management in Ontario.

Authors

null

Andrea Crespo

Cancer Care Ontario, Toronto, ON, Canada

Andrea Crespo, Daniela Gallo-Hershberg, Katherine Enright, Vishal Kukreti, Lorraine Martelli, Carlo DeAngelis, Anna Granic, Charmaine Mothersill, Ferid Rashid, Lily Spasic, Leslie Young, Jason Yu, Sarah McBain, Leta Marie Forbes

Organizations

Cancer Care Ontario, Toronto, ON, Canada, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada, Grand River Regional Cancer Centre, Kitchener, ON, Canada, St. Michael’s Hospital, Toronto, ON, Canada, Halton HealthCare, Oakville, ON, Canada, Southlake Regional Health Centre, Newmarket, ON, Canada, Kingston Health Sciences Centre, Kingston, ON, Canada, Royal Victoria Regional Health Centre, Barrie, ON, Canada

Research Funding

No funding received
None.

Background: Cancer medication-related infusion reactions (CMIRs) can lead to treatment delays, switching to less optimal therapy, or discontinuation. Variation in the prevention, management and reporting of CMIRs was identified as a quality and safety gap by Ontario clinicians. This initiative aimed to facilitate a standardized approach to CMIRs in Ontario through the development of user-friendly health-care provider and patient resources. Methods: A multidisciplinary working group of 15 oncology clinicians (oncologists, pharmacists, nurses, administrators) with experience in the management of CMIRs reviewed available literature on CMIR assessment, prevention and management. Recommendations were based on best available evidence and group consensus when only low-level evidence was available. Final guideline content was reviewed and validated by external experts. Complementary patient information was created based on best practices in health literacy and input from patient education experts, patients and caregivers. A mechanism for system-wide reporting to track CMIRs was explored. Results: A CMIR clinical practice guideline was created. Definitions, risk factors, prophylaxis strategies, an acute management algorithm and desensitization protocols are described. A CMIR severity grading system was proposed. A toolkit was developed and contains a table outlining risk factors, mechanism, incidence, symptoms, onset, prophylaxis, acute management and re-challenge by specific drug and a tool for calculating a three-bag 12-step desensitization. Patient-friendly information was also created. A new data element for collection of CMIR incidence and severity was added to the provincial Activity Level Reporting (ALR) data set to track CMIR trends. Conclusions: A review of current evidence and expertise from oncology clinicians resulted in an evidence-informed, consensus-based guideline. This guideline and the accompanying resources can help to facilitate safe and standardized prevention and management of CMIRs across Ontario. The collection of system-wide CMIR data based on the proposed grading system will inform future quality and safety improvement initiatives.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2019 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Patient Experience; Safety; Technology and Innovation in Quality of Care

Track

Patient Experience,Technology and Innovation in Quality of Care,Safety

Sub Track

Standardization Efforts to Improve Safety

Citation

J Clin Oncol 37, 2019 (suppl 27; abstr 255)

DOI

10.1200/JCO.2019.37.27_suppl.255

Abstract #

255

Poster Bd #

G6

Abstract Disclosures

Similar Abstracts

First Author: Ze Cong

Abstract

2021 ASCO Annual Meeting

Prevention of breast cancer in the general population: Is it a cultural issue?

First Author: Fernanda Estefanía Rivera

First Author: Marlid Cruz Ramos